CCM Concord Medical Corp: ערך חשבונאי למניה

Concord Medical Services generates revenue from Chinese diagnostic and radiotherapy centers, including the servicing of complex equipment. The book value per share clearly demonstrates the growth of net assets, where the -69.56 mark characterizes this parameter. Concord Medical Services implements advanced oncology treatment methods by integrating physics and medicine, while strictly adhering to radiation safety standards and equipment disposal regulations.

Institutional capital evaluates Concord Medical Services (CCM) through the lens of net equity available to shareholders after deducting all liabilities. The consolidated book value per share reflects the residual value of assets minus the depreciation of expensive equipment, allowing investors to determine the business's actual margin of safety amid high operating leverage and confirm the reliability of the investment.